MedRhythms announced that it received a final pricing determination from CMS for its InTandem rehabilitation system. InTandem delivers individualized, progressive rhythmic auditory stimulation (RAS) therapy in the home setting. It produces gait quality and speed improvements for post-stroke patients. This improves health outcomes and reduces the risk of adverse health events common in this patient […]
medrhythms
MedRhythms wins FDA breakthrough device designation for chronic stroke digital therapeutic
MedRhythms this week said it received FDA breakthrough device designation for its digital therapeutic device that treats chronic stroke walking deficits. The company uses sensors, music and software to create evidence-based, neurologic interventions to measure and improve walking. The device is currently being studied in a randomized controlled trial to evaluate the impact of the […]
Neurologic-focused digital therapeutics group MedRhythms raises $5m
Early stage medtech company MedRhythms said today it raised $5.3 million in a Series A round of financing to help support its platform intended to use neurologic interventions to measure and improve walking. The Portland, Maine-based company said it initially intended to raise $4 million, but found “substantial interest” and ended up netting extra funds. […]
